Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Hospitals & Diagnostics
    • Fujifilm India joins...

    Fujifilm India joins hands with Yashoda Super Speciality Hospital Kaushambi to end TB together

    GarimaWritten by Garima Published On 2019-03-26T09:30:07+05:30  |  Updated On 26 March 2019 9:30 AM IST
    Fujifilm India joins hands with Yashoda Super Speciality Hospital Kaushambi to end TB together

    Fujifilm India gears up to shoot down Tuberculosis with Yashoda Speciality Hospital Kaushambi


    New Delhi: Fujifilm India Pvt Ltd, a leader in the development and application of imaging and information innovations in healthcare technologies, in partnership with Yashoda Super Speciality Hospital, Kaushambi, Ghaziabad, organized an awareness program ‘TOGETHER END TB’ to help eradicate tuberculosis in India. The event was held at the Leela Ambience Conventional Hotel, New Delhi to mark the World TB day.


    A big population of India has been suffering from undetected tuberculosis for too long; late detection of disease increases their risk of transmitting the disease to others. India as a market is one of the major contributors to under-reporting and underdiagnosis of these cases in the world. While the burden of the disease is declining slowly worldwide, the progress in controlling disease and mitigating its consequences can be accelerated in the country. To expedite the cause, continuous and conscious efforts need to be taken for early diagnosis and treatment. The correct education and awareness from Hospitals and doctors is a crucial first step and can significantly contribute to the government’s vision of completely eradicating the disease from the country by 2025.


    Commenting on the occasion, Mr Haruto Iwata, Managing Director, Fujifilm India Pvt. Ltd. said, “Our association with Yashoda Super Speciality Hospital is a substantial step to fight against Tuberculosis in India. Reinforcing our commitment towards healthcare and the presence of the disease, we feel this is a great opportunity to create awareness amongst the public and take suitable measures to address this issue immediately”.


    Understanding this need, Fujifilm India looks to contribute towards the wellbeing of the people who are suffering from the disease and yet are unaware of its repercussions. The main objective of the program Together End TB is also to emphasize that incomplete or delayed treatment can be more serious and complicated.


    Further throwing light on the importance of early diagnosis of TB, Ms Upassana Arora Director Yashoda Super Speciality Hospital said “The longer the disease is left undetected, the higher the chance that the patient will end up transmitting the infection in the community. With our joint efforts with Fujifilm, we look at addressing the issue in order to achieve the goal of ‘End TB’ in India.”


    The program also encourages patients in India to complete their treatment cycle as ignorance or complacency can lead to MDR TB, which is even more dangerous and often not treatable.


    Explaining the objective of the program, Mr Chander Shekhar Sibal, Vice President, Head of Medical Division, Fujifilm India said, “Every year, in India close to 2 million people develop this disease with nearly 40% of them being infectious. Today’s program is our effort along with Yashoda Super Speciality Hospital to raise consciousness and promote advanced diagnosis and treatment of tuberculosis among patients.”


    As part of the program, Fujifilm has installed its state of the art Digital Radiography System ‘FDR Smart F’ at the hospital to offer free of cost check-ups to existing and potential patients. From the wide range of Fujifilm healthcare technologies, FDR Smart F digital radiography solution offers efficient workflow and excellent image quality for busy imaging centres.


    “Mapping the disease will help in predicting, preventing and treating a number of cases in the community. The collaboration will open up new possibilities and help in generating awareness among masses” said Dr Sunil Dagar General Manager - Operations & Quality talking about the roadmap to deal with the problem.


    Fujifilm is looking forward to expanding related free of cost services to a larger Indian population through partnerships with hospitals across India.


    Also Read: Biogen to sell biologics unit to Fujifilm for Rs 89 crore

    chander shekhar sibaldr sunil dagarend tberadicate tuberculosisFujifilmfujifilm healthcare technologiesFujifilm IndiaHaruto Iwatahealth careIndiainnovationsleela ambience conventional hotelMDR TBNew DelhipartnershipTBtogether end tbtreatmentTuberculosisupassana aroraworld tb dayyashoda super speciality hospital kaushambi

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Garima
    Garima

      Garima joined Medical Dialogues in the year 2017 and is currently working as a Senior Editor. She looks after all the Healthcare news pertaining to Medico-legal cases, MCI/DCI decisions, Medical Education issues, government policies as well as all the news and updates concerning Medical and Dental Colleges in India. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok